Public Employees Retirement Association of Colorado
AIMT

Public Employees Retirement Association of Colorado’s Aimmune Therapeutics AIMT Stock Holding History

Public Employees Retirement Association of Colorado’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-396,957
Closed -$13.7M – 1905
2020
Q3 		$13.7M Buy
+396,957
New +$8.45M 0.07% 213
2017
Q2 		– Sell
-33,000
Closed -$717K – 1835
2017
Q1 		$717K Sell
33,000
-64,403
-66% -$1.32M 0.01% 942
2016
Q4 		$1.99M Buy
+97,403
New +$1.99M 0.02% 569

Public Employees Retirement Association of Colorado's AIMT Position: Q4 2020 in Review

Public Employees Retirement Association of Colorado sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 396,957 shares — an estimated $13.7M sold.

Public Employees Retirement Association of Colorado first reported a position in AIMT in Q4 2016 and held it in 3 quarters. The position peaked at $13.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Public Employees Retirement Association of Colorado reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 396,957 Aimmune Therapeutics shares in Q4 2020, an estimated $13.7M.
  • Public Employees Retirement Association of Colorado first reported a position in Aimmune Therapeutics in Q4 2016 and held it in 3 quarters.
  • Public Employees Retirement Association of Colorado's Aimmune Therapeutics position peaked at $13.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2020, filed 11 Feb 2021.